Bioequivalence and Bioavailability Forum 12:54 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

FDA and outliers [Study As­sess­ment]

posted by mittyri - Russia, 2018-12-11 16:38  - Posting: # 19681
Views: 574

Dear Mann,

I don't think the position of FDA is different.
Please see this old post

Do you have any experience of BEQ analysis for submission in FDA/EMA jurisdiction?
Where is the idea of outliers coming from?
Do the results without any outliers analysis also show not-BE?

Kind regards,
Mittyri

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,032 posts in 4,059 threads, 1,299 registered users;
online 13 (1 registered, 12 guests [including 9 identified bots]).

When a distinguished but elderly scientist states that
something is possible, he is almost certainly right.
When he states that something is impossible,
he is very probably wrong.    Arthur C. Clarke

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed